Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Lab ; 69(2)2023 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-36787566

RESUMEN

BACKGROUND: Pseudomonas (P.) aeruginosa is one of the most common causes of nosocomial infections. The aim of this study was to explore the antibiotic resistance pattern and genetic association of P. aeruginosa strains isolated from Kermanshah hospitals and their surrounding areas. METHODS: The samples included both soils from around three hospitals and clinical specimens of the same hospitals. Once the samples were enriched and the colonies were isolated, the positive samples of this bacterium were confirmed using biochemical tests. Then, antibiotic susceptibility testing (AST) was performed using the disc diffusion method (DDM). Finally, the phylogenetic relationship between the isolates was examined using the rep-PCR technique. In all experiments, the standard strain (ATCC:27853) was used as a positive control. RESULTS: Thirteen and 36 (27 urines, 7 burns and 2 septa) isolates were detected from environmental and clinical samples, respectively. Results showed that clinical strains had the highest resistance to ceftriaxone (94.44%) and the lowest resistance to imipenem (72.2%). On the other hand, environmental strains around the hospital showed the highest resistance to amikacin (92.3%) and the lowest resistance to imipenem (53.84%). Overall, 46 patterns were observed in the strains. The dendrogram indicated that a number of clinical and environmental strains had close genetic similarities. Strains 35C and 9E (clinical strain 35 and environmental strain 9) were 100% similar, which could imply that they originated from a clonal strain. Also, strains 3C, 26C, and 13E were 100% similar. CONCLUSION: Despite the differences in antibiotic resistance pattern between hospital and environmental isolates, there were genetic similarities between the two isolates.


Asunto(s)
Antibacterianos , Infecciones por Pseudomonas , Humanos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Pseudomonas aeruginosa/genética , Infecciones por Pseudomonas/diagnóstico , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/microbiología , Filogenia , Imipenem , Reacción en Cadena de la Polimerasa , Hospitales , Pruebas de Sensibilidad Microbiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA